Endothelial-cell permeability and protein kinase C in pre-eclampsia

[1]  R. Dietz,et al.  High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. , 1997, Circulation research.

[2]  J. Davison.  Edema in pregnancy. , 1997, Kidney international. Supplement.

[3]  A. Busjahn,et al.  Endothelial adhesion molecules and leukocyte integrins in preeclamptic patients. , 1997, Hypertension.

[4]  F. Luft,et al.  Circulating leukocyte integrin expression in Wegener's granulomatosis. , 1996, Journal of the American Society of Nephrology : JASN.

[5]  R. Kirsch,et al.  Degradation of fibronectin in association with vascular endothelial disruption in preeclampsia. , 1995, The Journal of laboratory and clinical medicine.

[6]  F. Luft,et al.  Role of Protein Kinase C in Intracellular Signaling , 1994, Annals of the New York Academy of Sciences.

[7]  H. Davis,et al.  Mechanisms of cholera toxin prevention of thrombin- and PMA-induced endothelial cell barrier dysfunction. , 1994, Microvascular research.

[8]  N. Dean,et al.  Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. , 1994, The Journal of biological chemistry.

[9]  M. Brown,et al.  4 Volume homeostasis in normal pregnancy and pre-eclampsia: physiology and clinical implications , 1994 .

[10]  C. D. de Groot,et al.  Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation. , 1994, American journal of obstetrics and gynecology.

[11]  James M. Roberts,et al.  Pre-eclampsia: more than pregnancy-induced hypertension , 1993, The Lancet.

[12]  Joe G. N. Garcia,et al.  Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers , 1992, Journal of cellular physiology.

[13]  J. N. Martin,et al.  Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. , 1992, Clinical obstetrics and gynecology.

[14]  A. Goldfien,et al.  Sera From Preeclamptic Women Specifically Activate Human Umbilical Vein Endothelial Cells In Vitro: Morphological and Biochemical Evidence , 1992, American journal of reproductive immunology.

[15]  J. Roberts,et al.  Pathophysiology of preeclampsia. , 1991, Clinics in perinatology.

[16]  J. Roberts,et al.  High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. , 1991, American journal of obstetrics and gynecology.

[17]  J. Roberts,et al.  Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. , 1991, American journal of hypertension.

[18]  V. Briner,et al.  Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia. , 1991, Obstetrics and gynecology.

[19]  J. Roberts,et al.  Endothelial cell activation as a pathogenetic factor in preeclampsia. , 1991, Seminars in perinatology.

[20]  A. Malik,et al.  Increased endothelial albumin permeability mediated by protein kinase C activation. , 1990, The Journal of clinical investigation.

[21]  M. Lindheimer,et al.  Preeclampsia: pathophysiology, diagnosis, and management. , 1989, Annual review of medicine.